Silkim Pharma
Novel Drugs Targeting Inflammatory Pathologies
StartupSilkim Pharma is a Ra'anana-based startup in the Health Tech & Life Sciences sector, established in 2013. Novel Drugs Targeting Inflammatory Pathologies. Silkim Pharma was founded by Dror Chevion and Prof. Mordechai (Mottie) Chevion. The company has 1-10 employees. Core technologies: Biologicals.
The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageMature
- ProductReleased
- ModelB2B
- Employees1-10
- HQRa'anana
- DistrictCenter District
- Last RoundUndisclosed
Dror ChevionCo-founder & CEO
Prof. Mordechai (Mottie) ChevionCo-founder & CSO
1 article covered by sources including jlm-biocity.org.
What does Silkim Pharma do?
Silkim Pharma has developed a novel, protected platform of drugs for proven treatments of multiple indications. The company's platform is the result of extensive investigation of animal models of human diseases. Members of the platform act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents. These modes of action jointly assist in treating the causes and/or symptoms of multiple indications.
Who founded Silkim Pharma?
Silkim Pharma was founded in 2013 by Dror Chevion (Co-founder & CEO), Prof. Mordechai (Mottie) Chevion (Co-founder & CSO).
What sector is Silkim Pharma in?
Silkim Pharma operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Silkim Pharma located?
Silkim Pharma is based in Ranana, Israel, Center District.